Previous studies have shown that DYNC1I1 can promote the progression and metastasis of gastric cancer [21, 22], colon cancer [23] and glioblastoma [24], but no study has found that DYNC1I1 has a biological function in LIHC and is a prognostic factor of LIHC. Here, DYNC1I1 is linked to glioblastoma.